Schizophenia Disorder Clinical Trials

8 recruiting

Schizophenia Disorder Trials at a Glance

8 actively recruiting trials for schizophenia disorder are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Altoona, Çankırı, and Beijing. Lead sponsors running schizophenia disorder studies include New York State Psychiatric Institute, Northwell Health, and Fraser Health.

Browse schizophenia disorder trials by phase

Treatments under study

About Schizophenia Disorder Clinical Trials

Looking for clinical trials for Schizophenia Disorder? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Schizophenia Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Schizophenia Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

Biomarkers to Enhance Early Schizophrenia Treatment

Schizophenia Disorder
Northwell Health180 enrolled2 locationsNCT06969755
Recruiting

A Novel Blood Test as a Biomarker in Mental Health

Depression - Major Depressive DisorderSubstance Use DisordersAlcohol Use Disorder+5 more
Fraser Health500 enrolled1 locationNCT06856161
Recruiting
Not Applicable

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

Smoking CessationSchizophenia Disorder
The Hong Kong Polytechnic University90 enrolled5 locationsNCT07441928
Recruiting
Not Applicable

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)

Schizoaffective DisorderSchizophenia Disorder
University of California, San Diego125 enrolled1 locationNCT06865937
Recruiting

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

Bipolar Disorder (BD)Schizophenia Disorder
Çankırı Karatekin University150 enrolled1 locationNCT07306468
Recruiting
Not Applicable

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study

DepressionBipolar Affective DisorderSchizophenia Disorder+1 more
Peking University325 enrolled1 locationNCT06831435
Recruiting
Not Applicable

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

Bipolar DisorderSchizoaffective DisorderSchizophenia Disorder+1 more
University of Pittsburgh111 enrolled4 locationsNCT07043803
Recruiting
Phase 4

Exercise and Olanzapine-samidorphan

Schizoaffective DisorderSchizophenia DisorderBipolar Disorder I or II+1 more
New York State Psychiatric Institute30 enrolled1 locationNCT06740890